Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients

Blood

Volumn 122, Issue 18, 2013, Pages 3206-3209

  Hira, Asuka ^a   Yabe, Hiromasa ^b   Yoshida, Kenichi ^c   Okuno, Yusuke ^c   Shiraishi, Yuichi ^d   Chiba, Kenichi ^d   Tanaka, Hiroko ^e   Miyano, Satoru ^d,e   Nakamura, Jun ^f   Kojima, Seiji ^g   Ogawa, Seishi ^c,h   Matsuo, Keitaro ⁱ   Takata, Minoru ^a   Yabe, Miharu ^b  

^a KYOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e THE UNIVERSITY OF TOKYO   (Japan)

^f University of North Carolina at Chapel Hill   (United States)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE DEHYDROGENASE 2; ALDEHYDE DEHYDROGENASE; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP I PROTEIN; FANCONI ANEMIA GROUP M PROTEIN; FANCONI ANEMIA GROUP P PROTEIN; FANCONI ANEMIA PROTEIN; UNCLASSIFIED DRUG; ALDH2 PROTEIN, HUMAN; FANCA PROTEIN, HUMAN; FANCC PROTEIN, HUMAN; FANCG PROTEIN, HUMAN; FANCONI ANEMIA GROUP C PROTEIN;

ARM MALFORMATION; ARTICLE; BIRTH WEIGHT; BONE MARROW DEPRESSION; CARDIOVASCULAR MALFORMATION; DISEASE COURSE; ENZYME ACTIVITY; FANCONI ANEMIA; FRAMESHIFT MUTATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; JAPAN; JAPANESE (PEOPLE); KIDNEY MALFORMATION; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SKELETON MALFORMATION; THUMB MALFORMATION; WHOLE EXOME SEQUENCING; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BONE MARROW DISEASE; CELL CULTURE; ETHNOLOGY; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; ASIAN;

ALDEHYDE DEHYDROGENASE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BONE MARROW DISEASES; CELLS, CULTURED; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; JAPAN;

EID: 84891599913     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-507962     Document Type: Article

References (25)

1. Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res. 2009;668(1-2):4-10.
2. Kim H, D’Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev. 2012;26(13):1393-1408.
3. Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature. 2013;493(7432):356-363.
4. Ridpath JR, Nakamura A, Tano K, et al. Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res. 2007;67(23):11117-11122.
5. Langevin F, Crossan GP, Rosado IV, Arends MJ, Patel KJ. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature. 2011;475(7354):53-58.
6. Garaycoechea JI, Crossan GP, Langevin F, Daly M, Arends MJ, Patel KJ. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature. 2012;489(7417):571-575.
7. Parmar K, D’Andrea A, Niedernhofer LJ. Mouse models of Fanconi anemia. Mutat Res. 2009; 668(1-2):133-140.
8. Crabb DW, Edenberg HJ, Bosron WF, Li TK. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J Clin Invest. 1989; 83(1):314-316.
9. Matsuo K, Hamajima N, Shinoda M, et al. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis. 2001;22(6):913-916.
10. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994; 84(5):1650-1655.
11. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95(2):422-429.
12. Tachibana A, Kato T, Ejima Y, et al. The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability. Hum Mutat. 1999;13(3):237-244.
13. Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Tajima K. Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehydrogenase 2 Glu487Lys polymorphism: analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomarkers Prev. 2006;15(5):1009-1013.
14. Kunishima S, Okuno Y, Yoshida K, et al. ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet. 2013;92(3):431-438.
15. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141-1154.
16. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001;28(10):909-915.
17. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73(2):391-396.
18. Chandrasekharappa SC, Lach FP, Kimble DC, et al; NISC Comparative Sequencing Program. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood. 2013;121(22):e138-e148.
19. Wagner JE, Tolar J, Levran O, et al. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood. 2004;103(8):3226-3229.
20. Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39(2):162-164.
21. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, Smogorzewska A. Mutations of the SLX4 gene in Fanconi anemia. Nat Genet. 2011; 43(2):142-146.
22. Stoepker C, Hain K, Schuster B, et al. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet. 2011;43(2):138-141.
23. Schuster B, Knies K, Stoepker C, et al. Whole exome sequencing reveals uncommon mutations in the recently identified Fanconi anemia gene SLX4/FANCP. Hum Mutat. 2013;34(1):93-96.
24. Ceccaldi R, Parmar K, Mouly E, et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell. 2012;11(1):36-49.
25. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science. 2008;321(5895): 1493-1495.